Ayman Mohammad

Ayman is a second-year medical student, who graduated from Harvard College with a concentration in Economics and a secondary in Global Health & Health Policy. Prior to starting medical school, Ayman worked at a NYC-based biotechnology company, Roivant Sciences, where he developed a passion for oncology and drug development. His interests include clinical and preclinical drug development and regulatory policy.